Literature DB >> 15158633

Genomic imprinting in disruptive spermatogenesis.

Cristina Joana Marques1, Filipa Carvalho, Mário Sousa, Alberto Barros.   

Abstract

The possibility of imprinting disease transmission by assisted reproductive technologies has been raised after births of children with Angelman's and Beckwith-Wiedemann's syndromes. To investigate whether imprinting defects were associated with disturbed spermatogenesis, we studied two oppositely imprinted genes in spermatozoan DNA from normozoospermic and oligozoospermic patients. In the mesodermal specific transcript gene (MEST), bisulphite genomic sequencing showed that maternal imprinting was correctly erased in all 123 patients. However, methylation of the H19 gene did not change in any of 27 normozoospermic individuals (0%, 95% CI 0-13%), compared with methylation changes in eight moderate (17%, 8-31%, p=0.026) and 15 severe (30%, 18-45%, p=0.002) oligozoospermic patients. Our data suggest an association between abnormal genomic imprinting and hypospermatogenesis, and that spermatozoa from oligozoospermic patients carry a raised risk of transmitting imprinting errors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15158633     DOI: 10.1016/S0140-6736(04)16256-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  72 in total

Review 1.  Gene-environment interaction and male reproductive function.

Authors:  Jonatan Axelsson; Jens Peter Bonde; Yvonne L Giwercman; Lars Rylander; Aleksander Giwercman
Journal:  Asian J Androl       Date:  2010-03-29       Impact factor: 3.285

Review 2.  The paternal epigenome and embryogenesis: poising mechanisms for development.

Authors:  Timothy G Jenkins; Douglas T Carrell
Journal:  Asian J Androl       Date:  2010-10-25       Impact factor: 3.285

Review 3.  Britain's new preimplantation tissue typing policy: an ethical defence.

Authors:  N R Ram
Journal:  J Med Ethics       Date:  2006-05       Impact factor: 2.903

4.  Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines.

Authors:  Kee-Pyo Kim; Alexandra Thurston; Christine Mummery; Dorien Ward-van Oostwaard; Helen Priddle; Cinzia Allegrucci; Chris Denning; Lorraine Young
Journal:  Genome Res       Date:  2007-11-07       Impact factor: 9.043

5.  Lack of association of MTHFR rs1801133 polymorphism and CTCFL mutations with sperm methylation errors in infertile patients.

Authors:  Cristina Camprubí; Marta Pladevall; Mark Grossmann; Nicolás Garrido; Maria C Pons; Joan Blanco
Journal:  J Assist Reprod Genet       Date:  2013-08-18       Impact factor: 3.412

Review 6.  Environmental epigenetics and effects on male fertility.

Authors:  Carlos Guerrero-Bosagna; Michael K Skinner
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

7.  Effect of temozolomide on male gametes: an epigenetic risk to the offspring?

Authors:  I Berthaut; D Montjean; L Dessolle; K Morcel; F Deluen; C Poirot; A Bashamboo; K McElreavey; C Ravel
Journal:  J Assist Reprod Genet       Date:  2013-05-08       Impact factor: 3.412

8.  Idiopathic male infertility is strongly associated with aberrant promoter methylation of methylenetetrahydrofolate reductase (MTHFR).

Authors:  Wei Wu; Ouxi Shen; Yufeng Qin; Xiaobing Niu; Chuncheng Lu; Yankai Xia; Ling Song; Shoulin Wang; Xinru Wang
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

9.  From the Cover: Sperm Molecular Biomarkers Are Sensitive Indicators of Testicular Injury following Subchronic Model Toxicant Exposure.

Authors:  Edward Dere; Shelby K Wilson; Linnea M Anderson; Kim Boekelheide
Journal:  Toxicol Sci       Date:  2016-07-27       Impact factor: 4.849

10.  DNA methylation errors at imprinted loci after assisted conception originate in the parental sperm.

Authors:  Hisato Kobayashi; Hitoshi Hiura; Rosalind M John; Akiko Sato; Eiko Otsu; Naoko Kobayashi; Rei Suzuki; Fumihiko Suzuki; Chika Hayashi; Takafumi Utsunomiya; Nobuo Yaegashi; Takahiro Arima
Journal:  Eur J Hum Genet       Date:  2009-05-27       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.